Apyx Medical (APYX) Income towards Parent Company (2011 - 2026)

Apyx Medical (APYX) has reported Income towards Parent Company for 16 consecutive years, with -$3.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company rose 17.82% year-over-year to -$3.1 million; the trailing twelve-month figure through Jun 2026 stood at -$8.9 million (up 39.15% YoY), and the FY2025 full-year result was -$11.6 million, up 44.51% from the prior year.
• Income towards Parent Company retreated to -$3.1 million in Q2 2026 per APYX's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$1.0 million in Q2 2023 and bottomed at -$9.6 million in Q4 2023.
• Historically, Income towards Parent Company has averaged -$4.4 million across 5 years, with a median of -$4.4 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Income towards Parent Company surged 81.3% in 2023, then slumped 546.32% in 2024.
• Over 5 years, Income towards Parent Company stood at -$6.1 million in 2022, then tumbled by 58.68% to -$9.6 million in 2023, then jumped by 79.55% to -$2.0 million in 2024, then increased by 12.86% to -$1.7 million in 2025, then tumbled by 79.13% to -$3.1 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$3.1 million, -$2.1 million, and -$1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.